Single Nuclei RNA-Seq to map progression of non-alcoholic fatty liver disease (NAFLD) in patients II
Single-nucleus RNA-seq · human · 59 samples
- What it is
- Single-nucleus RNA-seqGene activity measured in individual nuclei (used when whole cells are hard to isolate, for example from frozen tissue). Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 59 samples: 59 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Acquisition of epithelial plasticity in human chronic liver diseaseNature · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE202379_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA835824 and SRA study SRP374021. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 59 sample titles: 59 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6112209 P70-NASH w/o cirrhosis-B-SITTA3
- GSM6112210 P48-NASH w/o cirrhosis-B-SITTA8
- GSM6112211 P77-NASH w/o cirrhosis-B-SITTB8
- GSM6112212 P78-NAFLD-B-SITTC8
- GSM6112213 P62-NASH w/o cirrhosis-B-SITTD3
- GSM6112214 P12-NASH with cirrhosis-B-SITTD8
- GSM6112215 P22-NASH with cirrhosis-B-SITTE8
- GSM6112216 P83-NASH w/o cirrhosis-B-SITTF12
- GSM6112217 P67-NASH w/o cirrhosis-B-SITTF3
- GSM6112218 P52-NASH w/o cirrhosis-C-SITTD9
- GSM6112219 P53-NASH w/o cirrhosis-C-SITTE9
- GSM6112220 P54-NASH w/o cirrhosis-C-SITTF9
- GSM6112221 P71-NASH w/o cirrhosis-C-SITTG1
- GSM6112222 P64-NASH w/o cirrhosis-D-SITTA6
- GSM6112223 P6-NAFLD-D-SITTA7
- GSM6112224 P49-NASH w/o cirrhosis-D-SITTA9
- GSM6112225 P50-NASH w/o cirrhosis-D-SITTB9
- GSM6112226 P51-NAFLD-D-SITTC9
- GSM6112227 P68-NASH with cirrhosis-D-SITTD5
- GSM6112228 P75-NASH with cirrhosis-D-SITTE5
- GSM6112229 P76-NASH w/o cirrhosis-D-SITTF5
- GSM6112230 P60-NAFLD-D-SITTG5
- GSM6112231 P7-NASH w/o cirrhosis-E-SITTB5
- GSM6112232 P19-NASH w/o cirrhosis-E-SITTB6
- GSM6112233 P8-NASH w/o cirrhosis-E-SITTC5
- GSM6112234 P20-NASH w/o cirrhosis-E-SITTC6
- GSM6112235 P9-NASH w/o cirrhosis-E-SITTD5
- GSM6112236 P21-NASH w/o cirrhosis-E-SITTD6
- GSM6112237 PHL2-Healthy control-E-SITTD9
- GSM6112238 PCL103-end stage-E-SITTE9
- GSM6112239 P15-NASH w/o cirrhosis-E-SITTF5
- GSM6112240 PCL103-end stage-E-SITTF9
- GSM6112241 P16-NASH w/o cirrhosis-E-SITTG5
- GSM6112242 PCL103-end stage-F-SITTD3
- GSM6112243 P30-Healthy control-G-SITTB7
- GSM6112244 P98-Healthy control-G-SITTF7
- GSM6112245 PCL16-end stage-H-SITTB12
- GSM6112246 PCL16-end stage-H-SITTC12
- GSM6112247 PCL16-end stage-H-SITTD12
- GSM6112248 PCL104-end stage-I-SITTD1
+ 19 more — browse all 59 samples with per-sample file links →
- GSE135251 TRANSCRIPTOMIC PROFILING ACROSS THE SPECTRUM OF NON-ALCOHOLIC FATTY LIVER DISEASE 216 samples shares non-alcoholic, fatty, liver
- GSE303271 RNA-seq of liver biopsies from patients with pediatric autoimmune liver disease 64 samples shares rna-seq, liver
- GSE210077 Single nuclei RNA-sequencing of normal and diseased liver 40 samples shares rna-seq, liver
- GSE326221 Acquired genetic and cell state changes in IDH-mutant glioma progression [snRNA-seq] 75 samples shares progression, rna-seq
- GSE339456 Integrated bulk and spatial transcriptomic analysis identifies progression-associated molecular signatures in biopsy-proven hypertensive nephropathy [RNA-seq] 35 samples shares progression, rna-seq
- GSE261713 Linking single cell genomes and transcriptomes at scale to decode breast cancer progression [scRNA-seq] 35 samples shares progression, rna-seq
- GSE333851 Spatial Glyco-Codes Define Human Liver Pathology and Progression 32 samples shares progression, liver
- GSE310058 Single-nucleus transcriptomic profiling of human lung tissue in chronic obstructive pulmonary disease (COPD) [snRNA-seq] 149 samples shares rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.